Cargando…
Characteristics of Patients with Mild to Moderate Primary Pulmonary Coccidioidomycosis
In Arizona, USA, primary pulmonary coccidioidomycosis accounts for 15%–29% of community-acquired pneumonia. To determine the evolution of symptoms and changes in laboratory values for patients with mild to moderate coccidioidomycosis during 2010–2012, we conducted a prospective 24-week study of pati...
Autores principales: | Blair, Janis E., Chang, Yu-Hui H., Cheng, Meng-Ru, Vaszar, Laszlo T., Vikram, Holenarasipur R., Orenstein, Robert, Kusne, Shimon, Ho, Stanford, Seville, Maria T., Parish, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036774/ https://www.ncbi.nlm.nih.gov/pubmed/24865953 http://dx.doi.org/10.3201/eid2006.131842 |
Ejemplares similares
-
Coccidioidomycosis in Patients Treated With Ruxolitinib
por: Kusne, Yael, et al.
Publicado: (2020) -
Impact of COVID-19 on diagnosis of primary pulmonary coccidioidomycosis
por: Ashcherkin, Nikita, et al.
Publicado: (2022) -
Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness
por: Blair, Janis E., et al.
Publicado: (2021) -
684 A Festering Affliction: Etiology and Clinical Manifestations of Thorn-Associated Infections
por: Simmons, Sierra, et al.
Publicado: (2014) -
Culture-Proven Thorn-Associated Infections in Arizona: 10-Year Experience at Mayo Clinic
por: Simmons, Sierra C., et al.
Publicado: (2017)